Evaluation of the Peritoneal Dialysis Program in a Hospital in Chinandega, Nicaragua.
NCT ID: NCT02270229
Last Updated: 2014-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
60 participants
OBSERVATIONAL
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of a Bimodal Solution for Peritoneal Dialysis
NCT01242904
The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis
NCT01195519
Improving Care for Peritoneal Dialysis Patients With the CKD-PD App
NCT04797195
Improving Outcomes in Peritoneal Dialysis
NCT02207751
Prevention of Peritonitis in Peritoneal Dialysis
NCT01293799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthcare providers
No interventions assigned to this group
PD patients
No interventions assigned to this group
Primary caregivers of the PD patients
No interventions assigned to this group
Laboratory personnel
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Being younger than 18 years of age
3. Refusal to participate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Baxter Healthcare Corporation
INDUSTRY
La Isla Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marvin Gonzalez, MD. MSc.
Role: PRINCIPAL_INVESTIGATOR
CISTA UNAN-Leon
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
rev5162014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.